Strides Pharma Science Share Price
1062.10+8.50 (+0.81%)
+18.48% past 1 Year
Strides Pharma Science (Strides) is a global pharmaceutical company that develops, manufactures, and markets a wide range of high-quality, affordable generic medicines. The company’s diverse portfolio spans complex generics across
Corporate filings & documents
Announcements
Strides receives USFDA Establishment Inspection Report (EIR) for flagship facility in Bengaluru
2 weeks agoStrides receives USFDA Establishment Inspection Report (EIR) for flagship facility in Bengaluru
2 weeks agoVoting results along with Scrutinizers report for 35th AGM.
2 weeks agoVoting results along with Scrutinizers report for 35th AGM.
2 weeks agoProceedings of 35th Annual General Meeting of the Company
2 weeks agoProceedings of 35th Annual General Meeting of the Company
2 weeks agoTranscript of Earnings Call pertaining to Unaudited Financial Results of the Company for the quarter ended June 30 2026.
1 month agoTranscript of Earnings Call pertaining to Unaudited Financial Results of the Company for the quarter ended June 30 2026.
1 month agoNewspaper advertisement - Unaudited Financial Results for the quarter ended June 30 2026
1 month agoNewspaper advertisement - Unaudited Financial Results for the quarter ended June 30 2026
1 month agoAudio Recording of Earnings Call dated July 31 2026 pertaining to unaudited financial results for Q1 FY27
1 month agoAudio Recording of Earnings Call dated July 31 2026 pertaining to unaudited financial results for Q1 FY27
1 month agoEarnings Presentation for the quarter ended June 30 2026
1 month agoEarnings Presentation for the quarter ended June 30 2026
1 month agoStrides Delivers Steady Performance with Q1FY27; Revenue at Rs. 12 654m Grew 13% YoY; Ex-US Markets Grew 17% YoY
1 month agoStrides Delivers Steady Performance with Q1FY27; Revenue at Rs. 12 654m Grew 13% YoY; Ex-US Markets Grew 17% YoY
1 month agoOutcome of Board Meeting of the Company held on July 31 2026
1 month agoOutcome of Board Meeting of the Company held on July 31 2026
1 month agoEarnings Call to discuss the Unaudited Financial Results of the Company for the quarter ended June 30 2026
1 month agoEarnings Call to discuss the Unaudited Financial Results of the Company for the quarter ended June 30 2026
1 month agoStrides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 inter alia to consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter ended June 30 2026 amongst other matters.
1 month agoStrides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 inter alia to consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter ended June 30 2026 amongst other matters.
1 month agoBusiness Responsibility and Sustainability Report for FY 2026
1 month agoBusiness Responsibility and Sustainability Report for FY 2026
1 month ago35th Annual General Meeting is scheduled to be held on Friday August 14 2026 at 12:15 hrs IST
1 month ago35th Annual General Meeting is scheduled to be held on Friday August 14 2026 at 12:15 hrs IST
1 month agoAnnual Report for FY 2025-26
1 month agoAnnual Report for FY 2025-26
1 month ago35th Annual General Meeting is scheduled on Friday August 14 2026 at 12:15 HRS IST.
1 month agoCompany has fixed the Record Date for Final Dividend for FY26 as Friday July 31 2026
1 month agoCompany has fixed the Record Date for Final Dividend for FY26 as Friday July 31 2026
1 month agoCertificate in terms of regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018
1 month agoCertificate in terms of regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018
1 month agoUpdate on Completion of Transaction relating to Pivot Path.
2 months agoUpdate on Completion of Transaction relating to Pivot Path.
2 months agoStrides Partners with Ascent Capital to Unlock Value in Pivot Path
2 months agoStrides Partners with Ascent Capital to Unlock Value in Pivot Path
2 months agoStrides Partners with Ascent Capital to Unlock Value in Pivot Path
2 months agoStrides Partners with Ascent Capital to Unlock Value in Pivot Path
2 months agoIntimation regarding closure of Trading Window for the quarter ended June 30 2026.
2 months agoIntimation regarding closure of Trading Window for the quarter ended June 30 2026.
2 months agoIntimation of Schedule of Analyst/ Institutional Investors Meet
2 months agoIntimation of Schedule of Analyst/ Institutional Investors Meet
2 months agoReminder to Shareholders regarding Unclaimed Dividends and Transfer to IEPF
3 months agoReminder to Shareholders regarding Unclaimed Dividends and Transfer to IEPF
3 months agoIntimation of Effective Date for Scheme of Demerger involving Arco Lab Private Limited ("Arco Lab") and ("Pivot Path Private Limited").
3 months agoSchedule of Analyst/ Institutional Investors Meeting - as enclosed.
3 months agoSchedule of Analyst/ Institutional Investors Meet - as enclosed.
3 months agoSchedule of Analyst/ Institutional Investors meet - as enclosed
3 months agoSchedule of Analyst/ Institutional Investors Meet - As enclosed.
3 months agoAnnual reports
Concalls & investor presentations
Jul 2026
May 2026
Jan 2026
Oct 2025
ConcallPresentation
Aug 2025
ConcallPresentation
Jul 2025
ConcallPresentation
May 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Oct 2024
ConcallPresentation
Jul 2024
ConcallPresentation
May 2024
ConcallPresentation
Jan 2024
Oct 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
Jan 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Jul 2022
ConcallPresentation
May 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Nov 2021
ConcallPresentation
Aug 2021
May 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Oct 2020
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-07-31
Dividend
5.0
2025-07-22
Dividend
4.0
2024-09-09
Dividend
2.5
2023-09-25
Demerger
Demerger
2023-08-04
Dividend
1.5
2021-08-05
Dividend
2.5
2020-07-24
Dividend
2.0
2019-08-22
Dividend
12.0
2019-07-19
Dividend
3.0
2018-09-12
Dividend
2.0
2017-09-07
Dividend
4.5
2016-07-21
Dividend
4.0
2015-07-22
Dividend
3.0
2014-10-16
Dividend
105.0
2014-09-01
Dividend
5.0
2013-12-19
Dividend
500.0
2013-05-30
Dividend
2.0
2012-05-14
Dividend
2.0
2011-05-18
Dividend
1.5
2010-05-21
Dividend
1.5
Company details
Registered office
Cyberone, Unit No. 902 Plot No - 4 & 6 Sector 30 A, Vashi Navi Mumbai Maharashtra PIN: 400703 Tel No: 022-27892924 / 3199 Fax No: 022-27892942 Email: [email protected] Internet: www.strides.com
Registrars
Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com
Management
Manjula Ramamurthy, Company Secretary & Compliance Officer
Arun Kumar, Chairman
Kausalya Santhanam, Non Executive Independent Director
Mukta Arora, Non Executive Independent Director
Homi Rustam Khusrokhan, Non Executive Independent Director
Ameet Hariani, Non Executive Independent Director
Subir Chakraborty, Non Executive Independent Director
Badree Komandur, Managing Director & Group Chief Executive Officer
Aditya Kumar, Non Executive Director
Ramaraju PVS, Executive Director
Details
BSE 532531
NSE STAR
ISIN INE939A01011